Pharmacogenetics: the slow, the rapid, and the ultrarapid.
作者信息
Meyer U A
机构信息
Department of Pharmacology, University of Basel, Switzerland.
出版信息
Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):1983-4. doi: 10.1073/pnas.91.6.1983.
Abstract
摘要
相似文献
1
Pharmacogenetics: the slow, the rapid, and the ultrarapid.药物遗传学：慢代谢型、快代谢型和超快代谢型。
Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):1983-4. doi: 10.1073/pnas.91.6.1983.
2
Pharmacogenetic polymorphism of drug metabolism.
N Z Med J. 1984 Aug 22;97(762):567-9.
3
Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity.异喹胍的药物遗传学及其作为CYP2D6羟化能力标志物的应用。
Pharmacogenomics. 2009 Jan;10(1):17-28. doi: 10.2217/14622416.10.1.17.
4
5
Pharmacogenetics and its clinical implications. Part II. Oxidation polymorphism.药物遗传学及其临床意义。第二部分。氧化多态性。
Ration Drug Ther. 1988 Jun;22(6):1-8.
6
Pharmacogenetics: Part I.药物遗传学：第一部分。
Ann Pharmacother. 1992 Jan;26(1):121-6. doi: 10.1177/106002809202600123.
7
Pharmacogenetics: Part II.药物遗传学：第二部分。
Ann Pharmacother. 1992 Feb;26(2):255-61. doi: 10.1177/106002809202600223.
8
9
Moving toward genetic profiling in patient care: the scope and rationale of pharmacogenetic/ecogenetic investigation.迈向患者护理中的基因图谱分析：药物遗传学/生态遗传学研究的范围及基本原理。
Drug Metab Dispos. 2001 Apr;29(4 Pt 2):580-5.
10
[Genetic causes for the variability of effects and side effects of drugs].[药物效应和副作用变异性的遗传原因]
Internist (Berl). 1982 Nov;23(11):601-9.
引用本文的文献
1
Pharmacogenetics and the treatment of functional gastrointestinal disorders.药物遗传学与功能性胃肠疾病的治疗
Pharmacogenomics. 2017 Jul;18(11):1085-1094. doi: 10.2217/pgs-2017-0049. Epub 2017 Jul 7.
2
Addressing phenoconversion: the Achilles' heel of personalized medicine.应对表型转换：个性化医疗的致命弱点。
Br J Clin Pharmacol. 2015 Feb;79(2):222-40. doi: 10.1111/bcp.12441.
3
Genetic Polymorphism of Cytochrome p450 (2C19) Enzyme in Iranian Turkman Ethnic Group.伊朗土库曼族细胞色素P450（2C19）酶的基因多态性
Oman Med J. 2013 Jul;28(4):237-44. doi: 10.5001/omj.2013.69.
4
Genetic polymorphism of CYP2C19 in Maharashtrian population.马哈拉施特拉邦人群中CYP2C19的基因多态性。
Eur J Epidemiol. 2007;22(12):907-15. doi: 10.1007/s10654-007-9196-0. Epub 2007 Nov 3.
5
Association between the CYP1A1 gene polymorphism and susceptibility to emphysema and lung cancer.CYP1A1基因多态性与肺气肿及肺癌易感性之间的关联。
Clin Mol Pathol. 1995 Aug;48(4):M210-4. doi: 10.1136/mp.48.4.m210.
6
CYP2D6 genotype and phenotype determination in a Mexican Mestizo population.墨西哥梅斯蒂索人群中CYP2D6基因分型与表型测定
Eur J Clin Pharmacol. 2005 Nov;61(10):749-54. doi: 10.1007/s00228-005-0038-2. Epub 2005 Oct 26.
7
Inference from the relationships between linkage disequilibrium and allele frequency distributions of 240 candidate SNPs in 109 drug-related genes in four Asian populations.四个亚洲人群中109个药物相关基因的240个候选单核苷酸多态性（SNP）的连锁不平衡与等位基因频率分布之间关系的推断。
J Hum Genet. 2004;49(10):558-572. doi: 10.1007/s10038-004-0190-z. Epub 2004 Sep 11.
8
[Pharmacogenomics. What is relevant for the internal medicine specialist?].[药物基因组学。对内科专家而言有哪些相关内容？]
Internist (Berl). 2003 Dec;44(12):1524-30. doi: 10.1007/s00108-003-1066-6.
9
Pharmacogenomics: marshalling the human genome to individualise drug therapy.药物基因组学：利用人类基因组实现药物治疗个体化。
Gut. 2003 May;52 Suppl 2(Suppl 2):ii10-8. doi: 10.1136/gut.52.suppl_2.ii10.
10
Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer.异生物质代谢酶的多态性与癌症易感性
Environ Health Perspect. 1999 Feb;107 Suppl 1(Suppl 1):37-47. doi: 10.1289/ehp.99107s137.
本文引用的文献
1
Drug reactions enzymes, and biochemical genetics.药物反应、酶与生化遗传学
J Am Med Assoc. 1957 Oct 19;165(7):835-7. doi: 10.1001/jama.1957.72980250010016.
2
A method for the detection of atypical forms of human serum cholinesterase; determination of dibucaine numbers.一种检测人血清胆碱酯酶非典型形式的方法；地布卡因值的测定。
Can J Biochem Physiol. 1957 Jun;35(6):339-46. doi: 10.1139/y57-041.
3
Enzymatic deficiency in primaquine-sensitive erythrocytes.伯氨喹敏感红细胞中的酶缺乏。
Science. 1956 Sep 14;124(3220):484-5. doi: 10.1126/science.124.3220.484-a.
4
Localization of the CYP2D gene locus to human chromosome 22q13.1 by polymerase chain reaction, in situ hybridization, and linkage analysis.通过聚合酶链反应、原位杂交和连锁分析将CYP2D基因座定位于人类染色体22q13.1。
Genomics. 1993 Feb;15(2):430-2. doi: 10.1006/geno.1993.1082.
5
Regulation and mechanisms of mammalian gene amplification.哺乳动物基因扩增的调控与机制。
Adv Cancer Res. 1993;61:87-113. doi: 10.1016/s0065-230x(08)60956-2.
6
Evidence for a new variant CYP2D6 allele CYP2D6J in a Japanese population associated with lower in vivo rates of sparteine metabolism.在日本人群中发现一种新的CYP2D6变异等位基因CYP2D6J，其与司巴丁体内代谢率降低相关的证据。
Pharmacogenetics. 1993 Oct;3(5):256-63. doi: 10.1097/00008571-199310000-00005.
7
Debrisoquine oxidation polymorphism: phenotypic consequences of a 3-base-pair deletion in exon 5 of the CYP2D6 gene.异喹胍氧化多态性：CYP2D6基因第5外显子3个碱基对缺失的表型后果。
Pharmacogenetics. 1993 Jun;3(3):123-30.
8
Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine.细胞色素P450 CYP2D基因座中一个活性基因的遗传性扩增是导致异喹胍超快代谢的原因。
Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11825-9. doi: 10.1073/pnas.90.24.11825.
9
Amplification of an esterase gene is responsible for insecticide resistance in a California Culex mosquito.酯酶基因的扩增导致加利福尼亚库蚊对杀虫剂产生抗性。
Science. 1986 Aug 15;233(4765):778-80. doi: 10.1126/science.3755546.
10
Overreplication and recombination of DNA in higher eukaryotes: potential consequences and biological implications.高等真核生物中DNA的过度复制与重组：潜在后果及生物学意义
Proc Natl Acad Sci U S A. 1986 Apr;83(7):2157-61. doi: 10.1073/pnas.83.7.2157.
Zotero 插件